TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $133.0K2017: $2.61M2018: $51.49M2019: $103.71M2020: $271.03M2021: $351.41M2022: $363.33M2023: $434.00M2024: $560.00M2025: $673.00M$673.00M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$673.00M+20.2%
2024$560.00M+29.0%
2023$434.00M+19.5%
2022$363.33M+3.4%
2021$351.41M+29.7%
2020$271.03M+161.3%
2019$103.71M+101.4%
2018$51.49M+1871.5%
2017$2.61M+1863.9%
2016$133.0K—